Clinical Trial: Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Ruolo Prognostico Della Malattia Minima Residua Nella Leucemia Mieloide Acuta

Brief Summary: Study purpose is to assess the prognostic role of Minimal Residual Disease (defined as medullary expression of WT1 gene), performed at Baseline and during treatment according to clinical practice. MRD results will be relate to treatment outcome and survival analysis variables (Overall Survival, Disease Free Survival, Cumulative Incidence of Relapse)